Hints and tips:
...Astellas said on Monday that it would use cash and loans to buy the New Jersey-based company, formerly known as Ophthotech, for $40 a share, representing a premium of 22 per cent to the US company’s closing...
...In the past, the group has relied on mega mergers such as its $68bn purchase of Wyeth in 2009 to drive growth. But the White House’s tough approach on antitrust makes large deals much riskier....
...SeaGen — formerly known as Seattle Genetics — has four approved oncology treatments....
...Worse, Bausch Health — formerly known as Valeant Pharmaceuticals — paid $2.4bn more for it back in 2013....
...Bausch & Lomb, the eyecare unit of the company formerly known as Valeant Pharmaceuticals, had been aiming to raise up to $840mn, on Thursday evening but eventually sold at $18 per share, raising $630mn....
...Doodles raised $54mn in September as part of a funding round that included 776, the VC firm of Reddit co-founder Alexis Ohanian (perhaps best known as Serena Williams’ husband), and FTX....
...In its fresh assessment on Thursday, the CMA said Pfizer and Flynn had “exploited a loophole” by debranding the capsules, formerly known as Epanutin, giving them generic status in order to raise prices by...
...China has long identified fluorspar as a strategic resource and back in the late 1990s limited exports due to its importance to industries from agriculture, electronics and pharmaceuticals to aviation, space...
...The company formerly known as Valeant — which two years ago rebranded itself as Bausch Health after a string of scandals over pricing and accounting irregularities — is spinning off its eye-care business...
...Some, such as Christophe Weber at Takeda Pharmaceutical and Sarah Casanova at McDonald’s Japan, are regarded as successful....
...Investors say Pfizer is in much better shape than when he took the top job in 2010, shortly after the company had completed the ill-fated acquisition of Wyeth for $68bn....
...The current version, mostly acquired with Wyeth in 2009, includes brands such as Centrum supplements and ChapStick....
...But it subsequently took on a new portfolio when it acquired Wyeth in 2010....
...Allergan Inc – the drugmaker that is now a subsidiary of Allergan plc, formerly known as Actavis – has agreed to pay $15m to resolve claims that it violated securities law by failing to properly disclose...
...Canadian drugmaker Valeant Pharmaceuticals International Inc said Tuesday it will sell controversial prostate-cancer drug maker Dendron Pharmaceuticals to Chinese conglomerate Sanpower Group Co – which also...
...A Louisiana doctor who has brought a series of whistleblower lawsuits against pharmaceuticals companies is in line for a windfall from Pfizer that would take his total payout from fraud settlements close...
...Martoma had obtained non-public information about an experimental drug for Alzheimer’s that was being developed by listed companies Elan and Wyeth....
...Before Pfizer bought Wyeth in 2009, the two companies employed 124,000 people. Pfizer now employs 78,000. Mr Read is quite right about maximising returns over the long run, though....
...Considered as an efficiency play, the Wyeth deal worked. Odd, then, that shareholders of neither buyer nor seller were enthused by Monday’s announcement that Pfizer would pay $160bn for Allergan....
...When Pfizer revealed its most recent mega-merger, the $68bn takeover of Wyeth in 2009, Jeffrey Kindler, then chief executive, hailed the deal as “a powerful opportunity to transform our industry”....
...The agency, known as Nice, weighs the price of a treatment versus the benefit to patients measured by a formula called “quality-adjusted life years added” or qualy....
...The marriage between the makers of Viagra and Botox would, if consummated, create the world’s biggest pharmaceuticals group....
...Sanofi’s indication this month that it may sell or spin-off its animal health unit brought a reminder that divestments have been almost as important a part of the deals boom as acquisitions....
...Pharmaceuticals companies used to be research enterprises that discovered and developed drugs. Then they became marketing giants, skilled at selling as many blockbuster pills as possible....
...Allergan (formerly known as Actavis and before that as Watson) describes itself as pioneering a new model in the drug sector....
International Edition